Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 9, 2009

Tgen and Applied Biosystems Use SOLiD 3 System for Genomic Research

  • Applied Biosystems and the Translational Genomics Research Institute (TGen) will ally to research complex diseases using the firm’s SOLiD™ 3 System, a next-generation genomic analysis platform. The alliance will also involve the co-development of a bioinformatics analysis and visualization pipeline for the SOLiD platform.

    Under this alliance, five SOLiD 3 Systems will be used to build a sequencing pipeline in connection with patient-centric, medically directed resequencing on a cross section of patient samples.

    Six different projects focused on comprehensive characterization of genetic and molecular changes occurring within clinical cohorts for diseases like cancer, neurological disorders, and autoimmune diseases will be studied.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »